Anesthesia drug study halted after just 3 patients
NCT ID NCT03962725
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aimed to see if skipping a type of muscle relaxant during general anesthesia could lower the risk of serious lung complications in high-risk surgery patients. The trial was terminated early after enrolling only 3 participants, so no meaningful conclusions can be drawn. The study was designed for adults undergoing non-cardiac surgery with a breathing tube.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASPIRATION PNEUMONIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Spinal zaps could reboot breathing after brain injury
- Could the speed of anesthesia gas shape lung recovery after nose surgery?
- Which feeding route cuts pneumonia risk after stroke?
- Spinal cord zap may help people breathe again after neck injury
- Less oxygen during lung surgery may prevent collapse — a trial investigates
- Tweaking ventilator settings could ease breathlessness and cut PTSD risk in ICU survivors